Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC.
Saved in:
| Title: | Real-World Data on Combined EGFR-TKI and Crizotinib Treatment for Acquired and De Novo MET Amplification in Patients with Metastatic EGFR -Mutated NSCLC. |
|---|---|
| Authors: | Urbanska, Edyta M.1 (AUTHOR) edyta.maria.urbanska@regionh.dk, Grauslund, Morten2 (AUTHOR) morten.grauslund@regionh.dk, Koffeldt, Peter R.2 (AUTHOR) peter.rindom.koffeldt@regionh.dk, Truelsen, Sarah L. B.2 (AUTHOR) sarah.truelsen@regionh.dk, Löfgren, Johan O.3 (AUTHOR) johan.olof.loefgren@regionh.dk, Costa, Junia C.4 (AUTHOR) junia.cardoso.costa@regionh.dk, Melchior, Linea C.2 (AUTHOR) linea.cecilie.melchior@regionh.dk, Sørensen, Jens B.1,5 (AUTHOR), Santoni-Rugiu, Eric2,5 (AUTHOR) edyta.maria.urbanska@regionh.dk |
| Source: | International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13077. 25p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms241713077 |
